Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).

Patients with head and neck cancer experience complex and frustrating communication problems after surgery, yet patient communication during the in hospital postoperative period has received ...

A change in Medicare reimbursement for a prosthetic device that allows people who have had their voice box removed to speak has led some providers to stop offering the device or reducing the number of ...

CARPINTERIA, Calif.--(BUSINESS WIRE)--InHealth Technologies, maker of Blom-Singer® voice restoration and ENT products and a business unit of Freudenberg Medical, announces the commercial launch of ...

Patiala: A study conducted by a research scholar at Punjabi University by comparing the Punjabi speech patterns of the patients who underwent total laryngectomy with that of native Punjabi speakers ...

Despite findings of previous studies and published guidelines, nearly two-thirds of patients with T4a larynx ("voice box") cancer are not receiving a total laryngectomy (surgical removal of the larynx ...

Please provide your email address to receive an email when new articles are posted on . A majority of patients with T4a larynx cancer received larynx preservation chemoradiation rather than the ...

Organ loss due to late-stage cancer is a heavy burden on both the patient and the health care system. Total laryngectomy in patients with advanced laryngeal or hypopharyngeal carcinoma is lifesaving, ...

In summary, few clinical studies specifically address the communication needs, communication methods, or perceptions of communication among patients with head and neck cancer during the postoperative ...